TODAY'S HEADLINES

Antipsychotic can cause serious reaction: FDA

FDA is warning that the antipsychotic medicine olanzapine can cause a rare but serious reaction that can progress to affect other parts of the body, and lead to death. Read more

FDA warns about Diflucan during pregnancy

FDA urges cautious prescribing of oral fluconazole (Dilfucan) during pregnancy while it evaluates a study that found a possible increased risk of miscarriage with frequent use of the drug. Read more

CONTINUING PHARMACY EDUCATION

Keep your patients moving: An overview of treatment options for constipation

This month's CE activity, "Keep your patient moving: An overview of treatment options for constipation," is open for pharmacists and pharmacy technicians.
The goal of this program is to assist pharmacists and pharmacy technicians in their understanding of the role of linaclotide, lubiprostone, methylnaltrexone, and naloxegol in the treatment of constipation after conventional nonpharmacologic interventions and conventional laxatives such as bulking agents, osmotic laxatives, and stimulant laxatives have failed.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Top 5 facts to know about new lung cancer drug

FDA recently approved a new indication for afatinib (Gilotrif) for patients with squamous cell carcinoma of the lung. Here are the top 5 things to know about Gilotrif. Read more

May 13, 2016

National Managed Care Pharmacy Survey 2016

Your input is needed! Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, is seeking your opinion on the current state of pharmacy. Take the survey and you could win a $200 Visa gift card. Answer Now.

Related Articles

First drug approved for hallucinations in Parkinson's

FDA warns supplement firms over unapproved ingredient